⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL3155059 | 0.97 | CHRM1 (0.41) | — | |
| Alcohol SCHEMBL11264817 | 0.92 | TDP1 (0.42) | — | |
| SCHEMBL31047724 | 0.90 | MVD (0.42) | — | |
| SCHEMBL29702696 | 0.90 | MVD (0.42) | — | |
| SCHEMBL29333999 | 0.90 | MVD (0.42) | — | |
| SCHEMBL1634020 | 0.79 | — | — | |
| SCHEMBL112280 | 0.79 | — | — | |
| SCHEMBL4586640 | 0.78 | TDP1 (0.38) | — | |
| SCHEMBL22540356 | 0.78 | — | — | |
| SCHEMBL9216352 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4651876-A1 | TARGETED THERANOSTIC AGENTS FOR IMAGING AND TREATING CANCER | The Board of Regents of the University of Texas System (US) | 2025-11-26 | — | — | EP | claimed |
| CN-120115713-A | Preparation method of smooth and compact silver-coated copper powder | 东方电气集团科学技术研究院有限公司 | 2025-06-10 | — | — | CN | claimed |
| EP-4547258-A1 | NANOPARTICLES AND TEMPLATE DIRECTED RIG-I AGONIST PRECURSOR COMPOSITIONS AND USES THEREOF FOR CANCER THERAPY | Transcode Therapeutics, Inc. (US) | 2025-05-07 | — | — | EP | claimed |
| WO-2024155993-A1 | TARGETED THERANOSTIC AGENTS FOR IMAGING AND TREATING CANCER | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-07-25 | — | — | WO | claimed |
| WO-2024006362-A1 | NANOPARTICLES AND TEMPLATE DIRECTED RIG-I AGONIST PRECURSOR COMPOSITIONS AND USES THEREOF FOR CANCER THERAPY | TRANSCODE THERAPEUTICS, INC. (US) | 2024-01-04 | — | — | WO | claimed |
| US-20230398243-A1 | THERAPEUTIC, RADIOLABELED NANOPARTICLES AND METHODS OF USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-12-14 | — | — | US | claimed |
| EP-4240429-A1 | THERAPEUTIC, RADIOLABELED NANOPARTICLES AND METHODS OF USE THEREOF | The General Hospital Corporation (US) | 2023-09-13 | — | — | EP | claimed |
| CN-113686834-B | Preparation method of SERS substrate integrating pyroelectric effect and plasmon resonance effect | 暨南大学 | 2023-04-18 | — | — | CN | claimed |
| WO-2022098768-A1 | THERAPEUTIC, RADIOLABELED NANOPARTICLES AND METHODS OF USE THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2022-05-12 | — | — | WO | claimed |
| CN-113686834-A | Preparation method of SERS substrate integrating pyroelectric effect and plasmon resonance effect | 暨南大学 | 2021-11-23 | — | — | CN | claimed |
| US-7723333-B2 | Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators | ASTRAZENECA AB (SE) | 2010-05-25 | — | — | US | claimed |
| EP-2076525-A2 | COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE | Wisconsin Alumni Research Foundation (US) | 2009-07-08 | — | — | EP | claimed |
| US-20090005353-A1 | Non-Anilinic Derivatives of Isothiazol-3(2H)-one 1,1-Dioxides as Liver X Receptor Modulators | ASTRAZENECA AB (SE) | 2009-01-01 | — | — | US | claimed |
| WO-2008067039-A9 | COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE | WISCONSIN ALUMNI RES FOUND (US) | 2008-10-16 | — | — | WO | claimed |
| US-20080171787-A1 | COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-07-17 | — | — | US | claimed |
| WO-2008067039-A2 | COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-06-05 | — | — | WO | claimed |
| EP-1838687-A1 | NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS | AstraZeneca AB (SE) | 2007-10-03 | — | — | EP | claimed |
| WO-2006073366-A1 | NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS | ASTRAZENECA AB (SE) | 2006-07-13 | — | — | WO | claimed |
| US-20030132416-A1 | Stripping solution | SHIPLEY COMPANY, L.L.C. | 2003-07-17 | — | — | US | claimed |
| US-4010149-A | PEPTIDE | SANKYO COMPANY LIMITED (JA) | 1977-03-01 | — | — | US | claimed |